Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10035232 | 0.89 | L3MBTL1 (0.32) | SMN1; SMN2L3MBTL1KDM4E | |
| SCHEMBL10035237 | 0.88 | ALDH1A1 (0.34) | ALDH1A1LMNAHTTSMN1; SMN2ACLY | |
| SCHEMBL28653745 | 0.87 | MAPT (0.34) | ALDH1A1MEN1KMT2ALMNAHTT | |
| SCHEMBL10035235 | 0.86 | ABCB1 (0.35) | ALDH1A1SMN1; SMN2L3MBTL1KDM4E | |
| SCHEMBL28662642 | 0.86 | MAPT (0.33) | ALDH1A1LMNAHTTSMN1; SMN2ACLY | |
| SCHEMBL10035231 | 0.84 | ALDH1A1 (0.32) | ALDH1A1LMNAHTTSMN1; SMN2ACLY | |
| SCHEMBL10035242 | 0.84 | CRHR1 (0.33) | CYP2C9 | |
| SCHEMBL10035239 | 0.82 | NR3C1 (0.31) | ALDH1A1SMN1; SMN2NR3C1L3MBTL1 | |
| SCHEMBL10035246 | 0.82 | NR3C1 (0.36) | ALDH1A1LMNASMN1; SMN2NR3C1MAPT | |
| SCHEMBL23061315 | 0.82 | ALDH1A1 (0.31) | ALDH1A1KMT2ALMNAHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178695-B2 | Applying to unwanted plants or weeds; controlling broadleaf plants | BAYER CROPSCIENCE AG (DE) | 2012-05-15 | — | — | US | disclosed |
| US-20080254990-A1 | 4-(3-Aminobenzoyl)-1,3-dimethylpyrazoles and their use as herbicides | BAYER CROPSCIENCE AG (DE) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080254990-A1 | 4-(3-Aminobenzoyl)-1,3-dimethylpyrazoles and their use as herbicides | DDT, TH, ABAT | ALDH1A1 135/4885MEN1 3727/4885KMT2A 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.